Insurers Battle Families Over Costly Drug for Fatal Disease

Thursday, June 22, 2017 - 19:21 in Health & Medicine

The case of Exondys 51 poses emotionally charged issues for families of young boys with a rare illness, who are fighting companies to get coverage for an expensive drug approved on a lower bar of proof.

Read the whole article on NY Times Science

More from NY Times Science

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net